<DOC>
	<DOCNO>NCT01045187</DOCNO>
	<brief_summary>Multicenter , non-randomized , feasibility study evaluate treatment ass acute safety FDA Cleared Axxent Electronic Brachytherapy System vaginal applicator intracavitary vaginal cuff treatment accord physician 's current standard care .</brief_summary>
	<brief_title>Feasibility Study Using Xoft System Treatment Endometrial Cancer</brief_title>
	<detailed_description />
	<mesh_term>Endometrial Neoplasms</mesh_term>
	<criteria>Most type endometrial ( uterine ) cancer Stage I Stage II ( see exclusion criterion ) Post hysterectomy Endometrial ( uterine ) cancer Stage IA Grade 1 Scleroderma Collagen vascular disease Active Lupus</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>endometrial cancer</keyword>
	<keyword>Uterine cancer</keyword>
	<keyword>electronic brachytherapy</keyword>
	<keyword>Xoft</keyword>
</DOC>